Assignee
FOX CHASE CANCER CENTER
US·26 granted patents·2 pending applications·731 citations·filing 1985–2022
Top patents by PatentIndex Score
28 records- 0192US5869245AMismatch endonuclease and its use in identifying mutations in targeted polynucleotide strandsFOX CHASE CANCER CENTER·Filed 1996·Granted Feb 9, 1999·175 cites·17 claims
- 0282US5202635ARadio frequency volume resonator for nuclear magnetic resonanceFOX CHASE CANCER CENTER·Filed 1991·Granted Apr 13, 1993·49 cites·50 claims
- 0382US2023372545A1Genetically modified human natural killer cell linesFOX CHASE CANCER CENTER·Filed 2022·Application pending·0 cites
- 0480US5550316ATransgenic animal model system for human cutaneous melanomaFOX CHASE CANCER CENTER·Filed 1993·Granted Aug 27, 1996·142 cites·2 claims
- 0578US5212450ARadio frequency volume resonator for nuclear magnetic resonanceFOX CHASE CANCER CENTER·Filed 1990·Granted May 18, 1993·47 cites·67 claims
- 0678US5194811ARadio frequency volume resonator for nuclear magnetic resonanceFOX CHASE CANCER CENTER·Filed 1990·Granted Mar 16, 1993·42 cites·51 claims
- 0774US5389514AMethod for specifically altering the nucleotide sequence of RNAFOX CHASE CANCER CENTER·Filed 1992·Granted Feb 14, 1995·48 cites·13 claims
- 0869US4937074AMethod of treating retrovirus infectionFOX CHASE CANCER CENTER·Filed 1988·Granted Jun 26, 1990·19 cites·13 claims
- 0967US6004958ACompounds and methods for therapeutic intervention in preventing diabetic complications and procedures for assessing a diabetic's risk of developing complications and determining the efficacy of therapeutic interventionFOX CHASE CANCER CENTER·Filed 1997·Granted Dec 21, 1999·34 cites·22 claims
- 1067US5599919ANucleic acid encoding a transiently-expressed kinetochore protein, and methods of useFOX CHASE CANCER CENTER·Filed 1994·Granted Feb 4, 1997·27 cites·6 claims
- 1161US5935937ACompositions and methods for inducing apoptosisFOX CHASE CANCER CENTER·Filed 1997·Granted Aug 10, 1999·20 cites·10 claims
- 1261US5360714AHepadnavirus polymerase gene product having RNA-dependent DNA priming and reverse transcriptase activities and methods of measuring the activities thereofFOX CHASE CANCER CENTER·Filed 1993·Granted Nov 1, 1994·26 cites·18 claims
- 1357US10450613B2EGFR/NEDD9/TGF-β interactome and methods of use thereof for the identification of agents having efficacy in the treatment of hyperproliferative disordersFOX CHASE CANCER CENTER·Filed 2016·Granted Oct 22, 2019·0 cites·2 claims
- 1457US5741646ACell lines and methods for screening growth regulatory compoundsFOX CHASE CANCER CENTER·Filed 1995·Granted Apr 21, 1998·24 cites·27 claims
- 1554US2016245817A1Mucin 5b as a pancreatic cyst fluid specific biomarker for accurate diagnosis of mucinous cysts and other markers useful for detection of pancreatic malignancyFOX CHASE CANCER CENTER·Filed 2016·Application pending·0 cites
- 1650US5231031AMethod for assessing risk of diabetes-associated pathologic conditions and efficacy of therapies for such conditionsFOX CHASE CANCER CENTER·Filed 1990·Granted Jul 27, 1993·19 cites·1 claims
- 1749US5681735ATranscription control element for increasing gene expression in myoblastsFOX CHASE CANCER CENTER·Filed 1993·Granted Oct 28, 1997·19 cites·17 claims
- 1847US4673575AComposition, pharmaceutical preparation and method for treating viral hepatitusFOX CHASE CANCER CENTER·Filed 1985·Granted Jun 16, 1987·16 cites·11 claims
- 1945US5869650ADendroamide compounds and their use in chemosensitizing multidrug resistant cellsFOX CHASE CANCER CENTER·Filed 1996·Granted Feb 9, 1999·3 cites·3 claims
- 2039US5492924APhorbine derivatives and their use in the diagnosis and therapy of cancerFOX CHASE CANCER CENTER·Filed 1993·Granted Feb 20, 1996·10 cites·13 claims
- 2137US5334525AHepadnavirus polymerase gene product having RNA-dependent DNA priming and reverse transcriptase activities and methods of measuring the activities thereofFOX CHASE CANCER CENTER·Filed 1992·Granted Aug 2, 1994·5 cites·18 claims
- 2234US5770717ANucleic acid encoding a stress-responsive subunit of human RNA polymerase IIFOX CHASE CANCER CENTER·Filed 1995·Granted Jun 23, 1998·2 cites·11 claims
- 2332US5716782ANucleic acid encoding a signal mediator protein that induces cellular morphological alterationsFOX CHASE CANCER CENTER·Filed 1995·Granted Feb 10, 1998·1 cites·17 claims
- 2430US5518886ABlood lead diagnostic assayFOX CHASE CANCER CENTER·Filed 1993·Granted May 21, 1996·3 cites·12 claims
- 2528US6124434ASignal mediator protein that induces cellular morphological alterationsFOX CHASE CANCER CENTER·Filed 1998·Granted Sep 26, 2000·0 cites·5 claims
- 2628US6100384AAntibodies immunologically specific for a signal mediator protein that induces cellular morphological alterationsFOX CHASE CANCER CENTER·Filed 1997·Granted Aug 8, 2000·0 cites·4 claims
- 2721US5801041AGene associated with suppression of tumor developmentFOX CHASE CANCER CENTER·Filed 1995·Granted Sep 1, 1998·0 cites·3 claims
- 2820US5821338AAntibodies specific for OVCA DNA encoded proteins and methods for their useFOX CHASE CANCER CENTER·Filed 1995·Granted Oct 13, 1998·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when FOX CHASE CANCER CENTER files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →